Immune impairments in multiple myeloma bone marrow mesenchymal stromal cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune impairments in multiple myeloma bone marrow mesenchymal stromal cells

Published:2014-10-24 Issue:2 Volume:64 Page:213-224
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

André Thibaud,Najar Mehdi,Stamatopoulos Basile,Pieters Karlien,Pradier Olivier,Bron Dominique,Meuleman Nathalie,Lagneaux Laurence

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-014-1623-y.pdf

Reference49 articles.

1. Kyle RA, Rajkumar SV (2004) Multiple myeloma. N Engl J Med 351:1860–1873. doi: 10.1056/NEJMra041875

2. Tucci M, Stucci S, Strippoli S, Dammacco F, Silvestris F (2011) Dendritic cells and malignant plasma cells: an alliance in multiple myeloma tumor progression? Oncologist 16:1040–1048. doi: 10.1634/theoncologist.2010-0327

3. Pratt G, Goodyear O, Moss P (2007) Immunodeficiency and immunotherapy in multiple myeloma. Br J Haematol 138:563–579. doi: 10.1111/j.1365-2141.2007.06705.x

4. Cook G, Campbell JD (1999) Immune regulation in multiple myeloma: the host–tumour conflict. Blood Rev 13:151–162. doi: 10.1054/blre.1999.0111

5. Feyler S, von Lilienfeld-Toal M, Jarmin S, Marles L, Rawstron A, Ashcroft AJ, Owen RG, Selby PJ, Cook G (2009) CD4(+)CD25(+)FoxP3(+) regulatory T cells are increased whilst CD3(+)CD4(-)CD8(-)alphabetaTCR(+) Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden. Br J Haematol 144:686–695. doi: 10.1111/j.1365-2141.2008.07530.x

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in immune subsets during chemotherapy as prognosis biomarkers for multiple myeloma patients by longitudinal monitoring;Immunologic Research;2024-09-10

2. Functionality of bone marrow mesenchymal stromal cells derived from head and neck cancer patients – A FDA-IND enabling study regarding MSC-based treatments for radiation-induced xerostomia;Radiotherapy and Oncology;2024-03

3. Treatment of medication-related osteonecrosis of the jaw with cell therapy;Frontiers in Cell and Developmental Biology;2024-01-26

4. IRE1a-Induced FilaminA Phosphorylation Enhances Migration of Mesenchymal Stem Cells Derived from Multiple Myeloma Patients;Cells;2023-07-26

5. Simultaneously Targeting Two Coupled Signalling Molecules in the Mesenchymal Stem Cell Support Efficiently Sensitises the Multiple Myeloma Cell Line H929 to Bortezomib;International Journal of Molecular Sciences;2023-05-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3